Literature DB >> 15132889

Diabetes in African Americans: unique pathophysiologic features.

Mary Ann Banerji1.   

Abstract

Type 2 diabetes is an increasing public health problem among African Americans, especially children. Several features make type 2 diabetes among African Americans unique. First, African-American adults with type 2 diabetes, or Flatbush diabetes, present with diabetic ketoacidosis. Patients are insulin resistant with acute, severe defects in insulin secretion and no islet cell autoantibodies. Following treatment, some insulin secretory capacity is recovered and ketoacidosis generally does not recur. The second is remission in African Americans with type 2 diabetes. Recovery of glucose homeostasis, accompanied by recovery of beta-cell function, follows intensive glycemic regulation. Finally, among African Americans with diabetes who are not obese, normal insulin sensitivity is not uncommon. Such individuals do not have the increased cardiovascular risk of insulin-resistant individuals. Differences in visceral, not subcutaneous, adipose tissue volume appear to determine insulin sensitivity. Understanding the unique physiologic and clinical features of African Americans is critical in designing appropriate treatment strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15132889     DOI: 10.1007/s11892-004-0027-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  53 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

3.  Extreme hyperglycemia and severe ketosis with spontaneous remission of diabetes mellitus.

Authors:  T O CHENG; R C JAHRAUS; E F TRAUT
Journal:  J Am Med Assoc       Date:  1953-08-15

4.  Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

Authors:  S I McFarlane; R L Chaiken; S Hirsch; P Harrington; H E Lebovitz; M A Banerji
Journal:  Diabet Med       Date:  2001-01       Impact factor: 4.359

5.  Trial of placebo in long-term chlorpropamide-treated diabetics.

Authors:  A Lev-Ran
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

6.  "Temporary diabetes" in adult Nigerians.

Authors:  B K Adadevoh
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

7.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

8.  Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).

Authors:  Julia Steinberger; Stephen R Daniels
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

9.  Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes.

Authors:  E Sobngwi; P Vexiau; V Levy; V Lepage; F Mauvais-Jarvis; H Leblanc; J C Mbanya; J F Gautier
Journal:  Diabet Med       Date:  2002-10       Impact factor: 4.359

10.  Insulin sensitivity, lipids, and blood pressure in young American blacks.

Authors:  B Falkner; H Kushner; T Tulenko; A E Sumner; J B Marsh
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

View more
  10 in total

1.  Improving outcomes in patients with acute coronary syndromes.

Authors:  Mustafa Tiewala; Alexander Perkevald; Cristina Ogrin; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 2.  Diabetes in African Americans.

Authors:  M C Marshall
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

3.  Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Authors:  David J Taber; Kelly J Hunt; Cory E Fominaya; Elizabeth H Payne; Mulugeta Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

4.  Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status.

Authors:  Lisa B Signorello; David G Schlundt; Sarah S Cohen; Mark D Steinwandel; Maciej S Buchowski; Joseph K McLaughlin; Margaret K Hargreaves; William J Blot
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

5.  Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Aurora Posadas; Caitlin Schaffner; Leonard E Egede; Prabhakar K Baliga
Journal:  J Am Coll Clin Pharm       Date:  2018-06-21

6.  Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.

Authors:  Andrew J Cole; Reginald W Johnson; Leonard E Egede; Prabhakar K Baliga; David J Taber
Journal:  Contemp Clin Trials Commun       Date:  2017-11-23

7.  Ketosis-Prone Type 2 Diabetes: A Case Series.

Authors:  Åke Sjöholm
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-16       Impact factor: 5.555

8.  Stimulated UCPCR Levels Are Lower in People With Type 1 Diabetes Than in Other Diabetes Types in Sub-Saharan Africa: Results From a Preliminary Cross-Sectional Study.

Authors:  Jean Claude Katte; Fanny Morfaw-Kibula; Batakeh B Agoons; Sylvain Zemsi; Magellan Guewo-Fokeng; Eugene Sobngwi
Journal:  Front Public Health       Date:  2022-04-08

9.  Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes.

Authors:  Swaraj Shrikant Waddankeri; Meenakshi Swaraj Waddankeri; Basavraj Gurushantappa Mangshetty
Journal:  Int J Endocrinol Metab       Date:  2021-03-07

10.  Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.

Authors:  Elizabeth J Mayer-Davis; Jennifer Beyer; Ronny A Bell; Dana Dabelea; Ralph D'Agostino; Giuseppina Imperatore; Jean M Lawrence; Angela D Liese; Lenna Liu; Santica Marcovina; Beatriz Rodriguez
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.